13 current guidelines, manuals and standards from WHO and other issuers — each with a GMJ summary, key points for clinicians and links across GMJ resources. Documents are linked to the issuer, never copied.
Browse by domain
Clinical Guidelines
Antimicrobial resistance 2Cancer 1Cardiovascular disease 0Communicable diseases 1Dermatology 0Diabetes & obesity 2Emergency & critical care 2Eye, ear & oral health 0Hepatitis 0HIV & STIs 2Malaria 0Neglected tropical diseases 0Neurology & dementia 1Noncommunicable diseases 1Nutrition in clinical care 0Palliative care 1Rehabilitation 0Respiratory disease 0Surgery & anaesthesia 0Tuberculosis 1Vaccine-preventable diseases 0Public Health & Prevention
Environmental & climate health 1Health promotion 2Immunization programmes 1Occupational health 0Oral health 0Oral health 0Physical activity & diet 2Road safety & injury 0Screening programmes 1Surveillance & outbreak response 3Tobacco, alcohol & drugs 0Vector control 0Humanitarian & Emergency Health
Ebola & filoviruses 2Health cluster coordination 0Natural hazards & disasters 0Refugee & migrant health 0WASH in emergencies 0Women, Child & Adolescent Health
Adolescent health 1Breastfeeding & infant nutrition 0Child health (IMCI) 2Child protection 0Family planning & contraception 1Gender-based violence 0Maternal health & obstetrics 0Newborn care 0Sexual & reproductive health 3Pharmacy, Laboratory & Technology
Blood safety 0Diagnostics 0Digital health 0Essential medicines 1Laboratory quality 0Medical devices & equipment 0Pharmacovigilance 0Prescribing & formularies 0Supply chain 0Latest records
Guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of HPV DNA genotyping
WHO · 2026 · Guideline · Evidence-based recommendations on using HPV DNA genotyping levels (extended, limited, no genotyping) for cervical cancer screening strategies tailored to programme follow-up capacity.
Guideline on public health and social measures for mitigating the risk and impact of epidemic and pandemic influenza
WHO · 2026 · Guideline · Evidence-based recommendations on non-pharmaceutical interventions to reduce influenza transmission in community settings for national and local health authorities.
Prevention of bloodstream infections and other infections associated with central venous catheters
WHO · 2026 · Guideline · Evidence-based recommendations for insertion, maintenance, access and removal of central venous catheters to prevent CLABSI
Guidelines for drinking-water quality: fourth edition incorporating the first, second and third addenda
WHO · 2026 · Guideline · Comprehensive WHO water safety framework for public health authorities, water suppliers, and surveillance agencies worldwide.
Guidelines for the clinical management of filovirus disease
WHO · 2026 · Guideline · Evidence-based recommendations for supportive care, fluid management, vasopressors and monitoring in Ebola, Marburg and related infections.
Guidelines for the clinical management of filovirus disease: executive summary
WHO · 2026 · Guideline · Evidence-based recommendations for clinicians treating Ebola, Marburg, Sudan, Bundibugyo and Taï Forest virus infections worldwide.
Guideline on doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men and transgender women
WHO · 2026 · Guideline · WHO recommendation on doxycycline PEP (200 mg within 72 hours after sex) to prevent bacterial STIs in MSM and transgender women.
Risk reduction of cognitive decline and dementia: WHO guidelines, second edition
WHO · 2026 · Guideline · Evidence-based recommendations for clinicians and public-health professionals on reducing dementia risk through managing modifiable factors
Consolidated HIV guidelines: service delivery
WHO · 2026 · Guideline · Evidence-based recommendations for people-centred, integrated HIV service delivery for clinicians and programme managers globally
Guidelines on expanding contraceptive options
WHO · 2026 · Guideline · Evidence-based recommendations on emerging contraceptive methods and extended-use practices for family planning programmes
Consolidated guidelines on tuberculosis: Module 4 – treatment and care, 2nd edition
WHO · 2026 · Guideline · Evidence-based recommendations for treating drug-susceptible and drug-resistant tuberculosis in adults, children, and adolescents worldwide
Integrated management of obesity in children
WHO · 2026 · Guideline · Evidence-based recommendations for managing obesity in children aged 29 days to under 10 years using a primary health care approach.
Guidelines on the integrated management of obesity in adolescents
WHO · 2026 · Guideline · Evidence-based recommendations for obesity management in adolescents (10–19 years) using a primary health care approach.

